OpenAlex
PricingAboutJobs
Log inGet started
Work

Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema

HTML

Year: 2017
Type: article
Source: Current Opinion in Ophthalmology
DOI: 10.1097/icu.0000000000000424
Authors: Sophie Cai, Neil M. Bressler
Institutions: Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Hospital
Language: English

Topic: Retinal Diseases and Treatments
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Keywords: diabetic macular edema, aflibercept, bevacizumab, ranibizumab, anti-VEGF therapy, intravitreal injection, visual acuity outcomes, baseline visual acuity, drug cost-effectiveness, eye safety, systemic safety
SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health
OpenAlex ID: W2750410498
FWCI: 15.39
Cites: 39
Cited by: 212
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security